Dashboard
Discussions
Watchlists
Collections
Tools
More
Events
𝛼
SK
or Search
SIGN UP
SIGN IN
ENTITY
Voronoi (310210 KS)
Watchlist
14
Analysis
Health Care
•
South Korea
Voronoi, Inc. operates as a drugs development company. The Company develops and manufactures kinase inhibitor and other new drugs. Voronoi provides services in Korea.
more
Watchlist
All
Insights
Primers
Broker
Sponsored
Syndicated
Podcast
Buy side
Refresh
Focused
Suggested
bearish
•
Bionote
•
31 May 2023 17:02
End of Mandatory Lock-Up Periods for 45 Companies in Korea in June 2023
We discuss the end of the mandatory lock-up periods for 45 stocks in Korea in June 2023, among which 6 are in KOSPI and 39 are in KOSDAQ.
Douglas Kim
Follow
510 Views
Share
bearish
•
LG Energy Solution
•
01 Jul 2022 02:31
End of Mandatory Lock-Up Periods for 40 Companies in Korea in July 2022
We discuss end of the mandatory lock-up periods for 40 stocks in Korea in July 2022.Among these 40 stocks, LG Energy Solution could face further...
Douglas Kim
Follow
675 Views
Share
bearish
•
Voronoi
•
14 May 2022 01:39
Voronoi: Reduces IPO Price Range by 25%
Voronoi is trying again to complete its IPO in Korea after lowering its IPO price range by 25% to 40,000 won to 46,000 won.
Douglas Kim
Follow
627 Views
Share
bullish
•
Voronoi
•
25 Jan 2022 00:51
Voronoi IPO Preview
Voronoi has developed a genotype-directed therapy that is effective for tumors caused by mutations in kinases, and has successfully conducted...
Douglas Kim
Follow
361 Views
Share
First
Previous
1
2
3
For Institutional Investors and Financial Services
For Corporate IR and Strategy
For Private Wealth Intermediaries
Pricing
How Smartkarma Compares
Who We Are
Careers
FAQs
Research Provider Solutions
Syndicate your Publications
Compliance
Terms of Use
Privacy Policy
Press Kit
RSS Feeds
Request a Free Trial
Avail a Transition Account
Guest Posts on Smartkarma
Other Enquiries
Join TL;DR Community
Free Weekly Newsletters
Copyright © 2022 Smartkarma Innovations Pte Ltd. All Rights Reserved. v3.70.5
x